Allergan Aesthetics (AbbVie) launches Faces of Natrelle breast implant testimonial program
- AbbVie's Allergan Aesthetics launched a nationwide Faces of Natrelle testimonial program inviting eligible breast implant patients to share stories.
- Selected submissions will be promoted across Natrelle social media, website and other Allergan/AbbVie brand channels.
- Nicole Mowad‑Nassar, Allergan Aesthetics president and AbbVie senior vice‑president, says the program honors women’s implant stories.
AbbVie's Allergan unit opens platform for breast implant patient stories
IRVINE, Calif., Feb 3, 2026 — Allergan Aesthetics, an AbbVie company, is launching a nationwide Faces of Natrelle® Testimonial Program that invites eligible breast augmentation and reconstruction patients to share their personal stories, photos or videos and written testimonials. The initiative is positioned as a patient-led resource to educate and support others considering breast surgery, and the company is promoting selected submissions across Natrelle® social media, its website and other brand channels.
Nicole Mowad-Nassar, President of Global Allergan Aesthetics and Senior Vice President at AbbVie, says the program is “about honoring the stories, the decisions, and the transformations of women with breast implants.” Allergan Aesthetics frames the campaign as a response to what it describes as outdated perceptions and a lingering culture of silence around breast procedures, noting that augmentation and reconstruction remain among the most commonly performed cosmetic and reconstructive surgeries in the United States.
The campaign emphasizes real-patient perspectives to offer clarity and confidence to those navigating elective or medically indicated breast procedures. By amplifying patient voices, the program aims to present a range of outcomes and experiences that may help prospective patients make more informed choices and feel less isolated in their decision-making process.
Submission criteria and compensation
Natrelle® is asking women who underwent augmentation or reconstruction at age 22 or older to submit a photo or video plus a written testimonial describing their experience with Natrelle® Breast Implants. Selected contributors are slated to appear on the brand’s digital and social channels, with content reviewed and approved by the company before use.
Selected augmentation patients who are Allē® Members may be eligible to receive a $500 Allē Gift Card as recognition, subject to terms and conditions, limited-time availability and eligibility limits; reconstruction patients are expressly excluded from compensation. The program underscores Natrelle®’s stated goal of championing women’s voices and reflecting diverse experiences throughout the breast aesthetics journey.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

